Hossain, Farah
Legend Biotech (United States)
2 papers on CoChatORCID 0009-0002-6577-0762
Most cited papers
- Verified
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Berdeja, J. G., Madduri, D., Usmani, S. Z., Jakubowiak, A., Agha, M., Cohen, A. D., Stewart, A. K., Hari, P., Htut, M., Lesokhin, A., et al. (2021) · The Lancet
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 1,756
- Verified
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome
Berry-Kravis, E. M., Lindemann, L., Jønch, A. E., Apostol, G., Bear, M. F., Carpenter, R. L., Crawley, J. N., Curie, A., Des Portes, V., Hossain, F., et al. (2018) · Nature Reviews Drug Discovery
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 336
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free